Spectroscopic diagnosis of anti-phospholipid antibodies by visible and near-infrared spectroscopy in SLE patients' plasma samples

Biochemical and Biophysical Research Communications

Volumn 362, Issue 2, 2007, Pages 522-524

  Nojima, Junzo ^a   Sakudo, Akikazu ^b   Hakariya, Yukiko ^b,c   Kuratsune, Hirohiko ^c,d   Watanabe, Yasuyoshi ^e   Kanakura, Yuzuru ^f   Ikuta, Kazuyoshi ^b  

^a OSAKA UNIVERSITY HOSPITAL   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c OSAKA CITY UNIVERSITY HOSPITAL   (Japan)

^d KANSAI UNIVERSITY OF WELFARE SCIENCES   (Japan)

^e OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti phospholipid antibodies; Anti phospholipid syndrome; Enzyme linked immunosorbent assay; Lupus anticoagulant activity; Systemic lupus erythematosus; Visible and near infrared spectroscopy

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; NEAR INFRARED SPECTROSCOPY; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; CALIBRATION; CHILD; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SPECTROSCOPY, NEAR-INFRARED;

EID: 34548280805     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.08.020     Document Type: Article

References (14)

1. Hughes G.R. The antiphospholipid syndrome: ten years on. Lancet 342 (1993) 341-344
2. Galli M., and Barbui T. Antiprothrombin antibodies: detection and clinical significance in the antiphospholipid syndrome. Blood 93 (1999) 2149-2157
3. Roubey R.A. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies. Blood 84 (1994) 2854-2867
4. Ginsberg J.S., Wells P.S., Brill-Edwards P., Donovan D., Moffatt K., Johnston M., Stevens P., and Hirsh J. Antiphospholipid antibodies and venous thromboembolism. Blood 86 (1995) 3685-3691
5. Greaves M. Antiphospholipid antibodies and thrombosis. Lancet 353 (1999) 1348-1353
6. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.C., Brey R., Derksen R., Harris E.N., Hughes G.R., Triplett D.A., and Khamashta M.A. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis. Rheum. 42 (1999) 1309-1311
7. Galli M., Luciani D., Bertolini G., and Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 101 (2003) 1827-1832
8. Triplett D.A. Lupus anticoagulants/antiphospholipid-protein antibodies: the great imposters. Lupus 5 (1996) 431-435
9. Atsumi T., Ieko M., Bertolaccini M.L., Ichikawa K., Tsutsumi A., Matsuura E., and Koike T. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis. Rheum. 43 (2000) 1982-1993
10. Nojima J., Kuratsune H., Suehisa E., Kitani T., Iwatani Y., and Kanakura Y. Strong correlation between the prevalence of cerebral infarction and the presence of anti-cardiolipin/β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies-Co-existence of these antibodies enhances ADP-induced platelet activation in vitro. Thromb. Haemost. 91 (2004) 967-976
11. Sakudo A., Suganuma Y., Kobayashi T., Onodera T., and Ikuta K. Near-infrared spectroscopy: promising diagnostic tool for viral infections. Biochem. Biophys. Res. Commun. 341 (2006) 279-284
12. Sakudo A., Kuratsune H., Kobayashi T., Tajima S., Watanabe Y., and Ikuta K. Spectroscopic diagnosis of chronic fatigue syndrome by visible and near-infrared spectroscopy in serum samples. Biochem. Biophys. Res. Commun. 345 (2006) 1513-1516
13. Nojima J., Kuratsune H., Suehisa E., Iwatani Y., and Kanakura Y. Acquired activated protein C resistance associated with IgG antibodies against β2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism. Clin. Chem. 51 (2005) 545-552
14. Nojima J., Iwatani Y., Suehisa E., Kuratsune H., and Kanakura Y. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus. Haematologica 91 (2006) 699-702